Xi Li is an accomplished professional in the field of biomedical engineering with a strong background in clinical market development and research. Currently serving as the Clinical Market Development Manager at Oxford Nanopore Technologies since June 2019, Xi has previously held significant roles at PacBio as Senior Manager of Clinical Marketing, Thermo Fisher Scientific as Senior Manager of Research & Development, and Agilent Technologies as Relationship Manager for Enterprise Business. Additionally, Xi was the Director of Research & Development at Vela Diagnostics from August 2011 to October 2015. Academic credentials include a Ph.D. in Biomedical Engineering from Nanyang Technological University Singapore and a Bachelor's degree in Biological Science from Tsinghua University.
